Prepared by Date Adopted Supersedes Procedure # / Dated William T. Pope, PhD and 3-31-09 Normal Ranges / 12-30-08 Christy O Brien, MT (ASCP) CHEMISTRY Acetone None detected Albumin, g/dl 3.5-5.0 Adult 2.8-4.6 0-1 month Alk. Phosphatase, u/l 30-112 Adult 40-190 14-16 years 50-272 12-14 years 75-275 2-12 years 60-260 0-2 years Ammonia, um/l 18-54 Amylase, u/l 22-132 Serum Bilirubin, Total, mg/dl 0.2-1.3 Adults Bilirubin, Neonatal, mg/dl 1-7.0 0-1 months >18 Bilirubin, Conjugated 0-0.2 BUN, mg/dl 5-22 Adult 5-20 0-17 months Calcium, mg/dl 8.5-10.2 Adult <6.0, >12.0 7.6-10.4 0-1 month Chloride, meq/l 99-109 Serum Cholesterol, mg/dl 114-200 Adult 114-170 1-19 years 53-170 0-1 years Cholesterol, HDL, mg/dl 40-70 Male 40-80 Female >60 Low CHD Risk Cholesterol, LDL, mg/dl 60-130 Desirable <100 Optimal / Low Risk CO2, meq/l 22-32 Adult <10, >40 CPK, u/l 39-195 Male 39-162 Female Creat., mg/dl 0.50-1.37 Adult Male 0.50-1.17 Adult Female 0.50-1.07 10-12 years 0.50-0.97 7-10 years 0.40-0.77 0-7 years QM-000 Page 1 of 1
CRP hs, mg/dl 0.02-0.722 Normal (95% of population) < 0.1 Low CHD Risk 0.1-0.3 Average CHD Risk > 0.30 High CHD Risk > 1.0 Suspect acute inflammation, repeat hscrp for CHD Risk assessment in 2 weeks. CSF Fl. Prot., mg/dl 15-45 20-80 <1 month Glucose, mg/dl 70-99 Adult <40 Outpatient, <1 month <50 Inpatient >500 All 100-125 Impaired fasting glucose GGT, u/l 6-39 > 3 months 12-80 1 3 months 30-150 <1 month Iron, ug/dl 38-160 Male 34-160 Female Iron-TIBC 245-435 Iron-%Sat. 20-50 K+, meq/l 3.5-5.0 Adult <2.5, >6.5 4.0-6.2 0-3 months Lactic Acid 0.5-2.2 Lipase, u/l 22-55 LDH, u/l 97-190 Adult 140-242 6 12 yrs 140-279 1 6 yrs 150-360 0-1 yr HDL Chol. 40-80 Female 40-70 Male > 60 Low CHD Risk LDL-Chol 60-130 Desirable < 100 Optimal / Low Risk Magnesium, mg/dl 1.7-2.5 <1.2, >4.9 Na+, meq/l 135-145 <120, >155 Osmolality, mosm/kg 275-295 PCHE Iu/L 4.2-14.0 QM-000 Page 2 of 2
Phosphorus, mg/dl 2.5-4.8 >12 yrs <1.0 3.0-5.6 3-12 yrs 3.6-6.0 1-3 yrs 3.5-6.6 < 1 yr SGOT (AST), u/l 5-38 Adult 15-62 0-3 months SGPT (ALT), u/l 5-37 Adult Total Protein, g/dl 6.2-8.0 > 3 yrs 5.6-7.5 1-3 yrs 5.1-7.3 0-1 yr Triglycerides, mg/dl 20-149 Uric Acid, mg/dl 2.5-7.7 Adult 2.3-6.7 9-13 yrs 1.8-5.0 0-9 yrs Calculated Values: BUN / Creatinine Ratio 6-22 Anion Gap 3.0-11.0 (Na C1 + CO2) Albumin / Globulin Ratio 1.2-3.1 TIBC, ug/ml 245-435 % SAT, % 20-50 Male 15-50 Female LDL, mg/dl 50-129 0-19 yrs 60-129 19-29 yrs 70-129 >29 yrs Blood Gas: ph 7.35-7.45 Arterial <7.2, >7.6 7.33-7.43 Venous PCO2, mm/hg 36-46 Arterial 38-48 Venous PO2, mm/hg 85-100 Arterial <50 25-47 Venous Coox: Total Hb, g/dl 14.5-16.5 Male 12.7-14.7 Female % O2 Hb, % 94-99 Male, Arterial 94-97 Female, Arterial 65-85 Venous CO Hb, % 0-1.5 Non-smokers <5, >20 <5.0 Smokers QM-000 Page 3 of 3
Met Hb, % 0.4-1.5 O2, vol.% 15-23 Ionized Calcium: CaIcium, mg/dl 4.2-5.1 ph 7.33-7.43 Venous Drug Therapeutic Range Toxic Range_ TDM & Toxicology: Acetaminophen, mg/dl < 20 >150 (4 hr. post dose) or > 40 (12 hr. post dose) Amikacin, ug/ml 20-25 Peak >30 1-8 Trough >8 4-8 Severe infections Carbamazepine, ug/ml 8-12 >20 Digoxin, ug/ml 0.8-2.0 >2.4 Gentamicin, ug/ml 5-10 Peak >12.0 1-2 Trough >2.0 Lithium, meq/l 0.5-1.3 >1.5 Pentobarbital, ug/ml 1-5 >10 20-40 Treatment of intracranial pressure with supportive therapy Phenobarbital, ug/ml 15-30 >50 Phenytoin, ug/ml 10-20 >30 (Dilantin) Phenytoin, Free, ug/ml 1.0-2.0 >2.5 Procainamide, ug/ml 4-8 >16 NAPA, ug/ml No ranges (Metabolite) Proca. + NAPA, ug/ml 6-25 >30 Quinidine, ug/ml 2-5 >10 Salicylate, mg/dl 2-29 Theophylline, ug/ml 10-20 Adults >25 6-11 Neonates >20 Tobramycin, ug/ml 4-10 Peak >12 1-2 Trough >2 Valproic Acid, ug/ml 50-100 >200 Vancomycin, ug/ml 20-40 Peak >80 QM-000 Page 4 of 4
5-10 Trough >20 Ethanol, mg/dl None Detected >300 Ethylene Glycol, mg/dl 0-5 >20 Isopropanol None Detected >150 Methanol None Detected >50 Urine Drug Screening None Detected Test Normal Range Urine & Manual Chemistries: Acetone None detected Creatinine, urine, g/24 hrs. 1.0-2.0 Male 0.8-1.8 Female Creatinine Clearance, mg/min 70-130 >3 years Calcium, urine, mg/24 hrs. 50-150 Avg. calorie diet 100-300 High Calorie diet Magnesium,urine, mg/24 hrs 73-122 Microalbumin, urine, mg/dl 0-1.9 Osmolality, urine, mosm/kg 390-1090 Protein, urine, mg/dl < 15 g/24 hrs. 0.05-0.15 Urea nitrogen, urine, g/24 hrs. 5-20 Uric Acid, urine, mg/24 hrs. 250-750 Urine Protein/Urine Creatinine Ratio <0.20 Sweat Chloride, meq/l 45-60 L/S Ratio, Amniotic fluid > 2.3 consistent with fetal lung maturity < 1.5 suggestive of fetal lung immaturity Phosphotidyl Glycerol, Amniotic Fl > 1.9 ug/ml Positive fetal lung maturity > 0.5 1.9 Wk Pos suggests fetal lung maturity < 0.5 Negative indeterminate for lung maturity QM-000 Page 5 of 5
Immunoassay / Immunology Test Normal Range ACTH, pg/ml 10-60 AFP (tumor marker), ng/ml <9 Alpha 1 antitrypsin, mg/dl 75-190 Anti-Thyroid Peroxidase AB, IU/ml 0-34 B12, pg/ml 180-914 95 percentile <130 Deficiency >300 No deficiency BNP, pg/ml <100 C-Peptide, ng/ml 1.1-5.0 CA-125, U/ml <35 CA19-9, U/ml 0-34 CEA, ng/ml <3 Nonsmoker <5 Smoker Ceruloplasmin, mg/dl 22.9-49.0 CKMB, ng/ml 0.6-6.3 Complement C-3, mg/dl 86-184 Complement C-4, mg/dl 20-59 Cortisol, ug/dl 7-25 AM 2-14 PM DHEA Sulphate, ug/dl 80-560 Male 35-430 Female Estradiol, pg/ml ND - 75 Male Female : <20-47 post-menopausal 27-122 mid-follicular 49-291 mid-luteal QM-000 Page 6 of 6
95-433 peri-ovulatory Ferritin, ng/ml 23.9-336 Male 11-306 Female Folate, ng/ml 3.0-20.0 2-4 Suggestive of deficiency Test Normal Range FSH, MIU/ml 1.27-19.26 Male Female: 3.85-8.78 mid-follicular 4.54-22.51 mid-cycle peak 1.79-5.12 mid-luteal 6.74-113.59 post-menopausal Haptoglobin, mg/dl 33-200 HCG, miu/ml 0-5 Male, Females <40 yrs <7 Female >40 yrs Hemoglobin A1C, % 4.2-6.0 Homocysteine, umol/l 4.4-12.5 < 7.2 Desirable IgA, mg/dl 90-440 IgG, mg/dl 70-1800 IgM, mg/dl 35-260 Insulin,uIU/ml 1.9-23 Fasting LH, MIU/ml 1.0-5.8 Child 1.24-8.62 Male Female: 2.12-10.89 mid-follicular 19.18-103.03 mid-cycle peak 1.2-12.86 mid-luteal 10.97-58.64 post-menopausal Myoglobin, ng/ml 17.4-105.7 Male 14.3-65.8 Female PTH, pg/ml 11-67 PTH, Intraoperative, pg/ml 12-72 QM-000 Page 7 of 7
Prealbumin, mg/dl 18-38 Procalcitonin, ng/ml 0.05-0.09 >2.0 High risk of sepsis Progesterone, ng/ml 0.10-0.84 Male Female: 0.31-1.52 mid-follicular 5.16-18 mid-luteal ND - 0.78 post-menopausal 4.73-50.74 preg.-1 st trimester 19.41-45.3 preg.- 2 nd trimester Prolactin, ng/ml 2.64-13.13 Male Female: 3.34-26.72 pre-menopausal 2.74-19.64 post-menopausal Test Normal Range Prostate Specific Antigen, (PSA),ng/ml 0-4 0-2.5 40-49 years 0-3.5 50-59 years 0-4.5 60-69 years 0-6.5 >69 years Rheumatoid Factor, u/ml 0-25 RBC Folate, ng/ml 164-867 Testosterone, ng/dl 1-10 0-5 years 3-50 Male, 5-11 years 10-570 Male, 11-14 years 220-980 Male, 14-17 years 2-25 Female, 5-11 years 10-40 Female, 11-17 years T3, Free, pg/ml 2.5-3.9 T3, Total, ng/dl 87-178 T4, ug/dl 5.8-12.0 T4, Free (measured), ng/dl 0.58-1.60 FTI 5.93-13.1 T-Uptake, % 32-48.4 TSH, uiu/ml 0.34-5.6 Thyroglobulin, ng/ml <33 >16 yrs (tumor marker) <5 Athyrotic Thyroglobulin Antibodies, IU/ml <4 QM-000 Page 8 of 8
Transferrin, mg/dl 181-340 Troponin, ng/ml < 0.09 > 0.10 Cardiac Injury Test Normal Range_ Electrophoresis: Hemoglobin Elect. AA Pattern Fetal Hemoglobin 55 85% At birth 2.1% > 2 years Protein Elect. Total protein, g/dl 5.1-7.3 0-1 month 5.6-7.5 3-12 months 6.2-8.0 >3 years Albumin, g/dl 3.2-4.8 0-3 months 3.7-5.7 3-12 months 3.3-5.8 12-24 months 3.5-5.0 > 2 years Alpha -1, g/dl 0.1-0.3 0-2 months 0.2-0.6 > 2 months Alpha 2, g/dl 0.2-0.6 0-1 month 0.3-0.7 1-3 months 0.5-1.1 3-12 months 0.4-1.0 12-24 months 0.5-0.9 >2 years QM-000 Page 9 of 9
Beta, g/dl 0.3-0.6 0-1 month 0.3-0.7 1-3 months 0.4-1.0 3-12 months 0.3-1.2 12-24 months 0.6-1.1 >2 years Gamma, g/dl 0.6-1.2 0-1 month 0.2-0.7 1-3 months 0.2-0.9 3-12 months 0.4-1.4 12-24 months 0.7-1.7 >2 years HEMATOLOGY CBC: WBC, K/mm³ 5.0-38.0 0-1 month 6.0-17.5 1 month-2 yrs 4.5-15.5 2-9 yrs 4.5-13.5 9 18 yrs 3.07-11.77 >18 yrs RBC, M/mm³ 3.00-6.60 0-1 month <2.00, >7.00 2.70-5.30 1 month-2 yrs 3.90-5.30 2-9 yrs 4.50-5.30 Male, 9-18 yrs 4.10-5.10 Female, 9-18 yrs 4.28-5.48 Male, >18 yrs 3.76-5.20 Female, >18 yrs Hemoglobin, gm/dl 10.0-22.5 0-1 month <6.9, >25 9.0-13.5 1 month-2 yrs <6.0 11.5-15.5 2-9 yrs QM-000 Page 10 of 10
13.0-16.0 Male, 9-18 yrs 12.0-16.0 Female, 9-18 yrs 12.9-16.9 Male, >18 yrs 11.6-15.6 Female, >18 yrs Hematocrit, % 39-67 0-1 month <20, >75 28-42 1 month-2 yrs <19 34-45 2-9 yrs 37-49 Male, 9-18 yrs 36-46 Female, 9-18 yrs 39-49 Male, >18 yrs 34-46 Female, >18 yrs MCV, fl 85-126 0-1 month 70-115 1 month-2 yrs 75-95 2-9 yrs 78-98 Male, 9-18 yrs 78-102 Female, 9-18 yrs 81-98 >18 yrs MCH, uug 28-40 0-1 month 23-35 1 month-2 yrs 24-33 2-9 yrs 25-35 9-18 yrs 27-34 >18 yrs MCHC, % 28-38 0-1 month 29-37 1 month- 2 yrs 31-37 2-19 yrs 32-36 >18 yrs RDW, % 13.0-18.0 0-1 month 11.5-16.0 1 month-2 yrs 11.5-15.0 2-9 yrs 11.5-14.0 9-18 yrs 10.4-13.9 >18 yrs Platelet, K/mm³ 129-355 <20, >1,000,000 QM-000 Page 11 of 11
MPV, fl 7.4-11.4 Differential: Neutrophils, % 40-80 Bands, % 0-10 Lymphocytes, % 15-40 Monocytes, % 0-10 Eosinophils, % 0-7 Basophils, % 0-2 Reticulocytes: Absolute Retic, M/mm³ 0.0226-0.1206 Male 0.0200-0.1168 Female % Retic, % 0.40-2.54 Male 0.49-2.55 Female Immature Retic Fraction 0.134 0.369 Male (IRF) 0.155-0.383 Female Sedimentation Rate, mm/hr 0-15 Male, 0-50 yrs (ESR) 0-20 Female, 0-50 yrs 0-20 Male, >50 yrs 0-30 Female, >30 yrs Hemoglobin Electrophoresis Phenotype AF 0-1 yr (qualitative) Phenotype AA >1 yr Eosinophil, Blood, mm³ <850 0-1 yr <600 > 1 yr Leukocyte Alkaline Phosphatase 32-182 (LAP score) Kleihauer-Betke, % fetal cells 0.00 QM-000 Page 12 of 12
Antithrombin III Activity, % 80-120 D-Dimer, ug/dl FEU < 0.46 Factor VIII, % 51-173 Factor IX, % 53-194 Fibrinogen, mg/dl 167-484 COAGULATION Heparin, IU/ml 0.5-1.0 LMW, Therapeutic 0.10-0.30 LMW, Prophylactic 0.3-0.7 Unfractionated, Therapeutic QM-000 Page 13 of 13
PT, sec 12.3-14.8 >45.8 (value Corresponding to INR>5.0) INR Refer to physician directed therapeutic target >5.0 PTT, sec 22.7-39.0 >150 PFA, sec 92-174 Epinephrine 54-104 ADP Protein C Activity, % 70-130 Protein S Activity, % 77-143 Male 60-123 Female Thrombin Time, sec 13.9-19.9 Thromboelastograph (TEG) R, min 5.6-10.0 K, min 1.0-3.0 AA, Deg 55-78 MA, mm 51-69 URINALYSIS Specific Gravity 1.001-1.035 ph 5.0-8.0 Protein Glucose Ketones Bilirubin Nitrite Negative Negative Negative Negative Negative QM-000 Page 14 of 14
Leukocyte Esterase Negative Urobilinogen 0.2-1.0 RBC, hpf 0-4 WBC, hpf 0-4 Hyaline cast, lpf 0-7 Squamous Epithelial, hpf 0-3 Bacteria None seen - Occasional Approved Reviewed Reviewed Reviewed Reviewed Reviewed Date Signature QM-000 Page 15 of 15